797 related articles for article (PubMed ID: 9189124)
1. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
2. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
[TBL] [Abstract][Full Text] [Related]
3. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Lind P
Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
Fröberg AC; Valkema R; Bonjer HJ; Krenning EP
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):193-6. PubMed ID: 12552335
[TBL] [Abstract][Full Text] [Related]
5. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism.
Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Lind P
Invest Radiol; 1997 Aug; 32(8):459-65. PubMed ID: 9258734
[TBL] [Abstract][Full Text] [Related]
6. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands.
Ishibashi M; Nishida H; Hiromatsu Y; Kojima K; Tabuchi E; Hayabuchi N
J Nucl Med; 1998 Feb; 39(2):320-4. PubMed ID: 9476944
[TBL] [Abstract][Full Text] [Related]
7. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands.
Vallejos V; Martin-Comin J; Gonzalez MT; Rafecas R; Muñoz A; Fernãndez A; Mora J; Ramos M
Clin Nucl Med; 1999 Dec; 24(12):959-64. PubMed ID: 10595477
[TBL] [Abstract][Full Text] [Related]
8. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
[TBL] [Abstract][Full Text] [Related]
9. Quantitative comparison of technetium-99m tetrofosmin and thallium-201 images of the thyroid and abnormal parathyroid glands.
Giordano A; Marozzi P; Meduri G; Ficola U; Calcagni ML; Vaccaro A; Rubini G; Attard M; Li Puma M; Ricci R; Corsello S
Eur J Nucl Med; 1999 Aug; 26(8):907-11. PubMed ID: 10436206
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique.
Rubello D; Saladini G; Casara D; Borsato N; Toniato A; Piotto A; Bernante P; Pelizzo MR
Clin Nucl Med; 2000 Jul; 25(7):527-31. PubMed ID: 10885694
[TBL] [Abstract][Full Text] [Related]
11. Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism.
Casara D; Rubello D; Pelizzo MR; Shapiro B
Eur J Nucl Med; 2001 Sep; 28(9):1351-9. PubMed ID: 11585294
[TBL] [Abstract][Full Text] [Related]
12. [Use of 99mTc-tetrofosmin scintigraphy in the diagnosis of patients with hyperparathyroidism].
Vallejos V; Martín-Comín J; Mora J; González MT; Rafecas A; Muñoz A; Fernández A; Castell M; Ricard Y; Ramos M
Rev Esp Med Nucl; 1998; 17(2):94-101. PubMed ID: 9611279
[TBL] [Abstract][Full Text] [Related]
13. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study).
Taillefer R; Boucher Y; Potvin C; Lambert R
J Nucl Med; 1992 Oct; 33(10):1801-7. PubMed ID: 1328564
[TBL] [Abstract][Full Text] [Related]
14. Localization of parathyroid glands using technetium-99m-tetrofosmin imaging.
Ishibashi M; Nishida H; Strauss HW; Kojima K; Fujito H; Watanabe J; Hiromatsu Y; Hayabuchi N
J Nucl Med; 1997 May; 38(5):706-11. PubMed ID: 9170432
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.
Leslie WD; Dupont JO; Bybel B; Riese KT
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1566-70. PubMed ID: 12458389
[TBL] [Abstract][Full Text] [Related]
16. Kinetics of Tc-99m sestamibi and Tc-99m tetrofosmin in a case of parathyroid adenoma.
Mansi L; Rambaldi PF; Marino G; Pecori B; Del Vecchio E
Clin Nucl Med; 1996 Sep; 21(9):700-3. PubMed ID: 8879870
[TBL] [Abstract][Full Text] [Related]
17. [Disagreement between findings of 99mTc-MIBI and 99mTc-pertechnetate scintigraphy scans in patients with primary hyperparathyroidism].
Dolezal J; Horácek J; Ceeová V; Vizd'a J
Vnitr Lek; 2004 Jan; 50(1):72-5. PubMed ID: 15015233
[TBL] [Abstract][Full Text] [Related]
18. [Various dynamics of Tc-99m-tetrofosmin and Tc-99m-MIBI in a parathyroid adenoma].
Nowak B; Sabri O; Hoff C; Reinartz P; Kleinhans E; Zimny M
Nuklearmedizin; 1999; 38(5):160-3. PubMed ID: 10488484
[TBL] [Abstract][Full Text] [Related]
19. [Use of a gamma probe for intraoperative localization of parathyroid adenomas with Tc-99m-tetrofosmin and Tc-99m-sestamibi].
Gallowitsch HJ; Fellinger J; Kresnik E; Mikosch P; Pipam W; Unterweger OF; Lind P
Acta Med Austriaca; 1997; 24(2):73-8. PubMed ID: 9273810
[TBL] [Abstract][Full Text] [Related]
20. [The role of scintigraphy with dual tracer and potassium perchlorate (99mTcO4 & KClO4/ MIBI) in primary hyperparathyroidism].
Rubello D; Saladini G; Casara D
Minerva Endocrinol; 2001 Mar; 26(1):13-21. PubMed ID: 11323563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]